We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+22.86%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$16B
AUM Growth
+$2.39B
Cap. Flow
-$371M
Cap. Flow %
-2.31%
Top 10 Hldgs %
24.43%
Holding
979
New
49
Increased
147
Reduced
723
Closed
36

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$101M
2
ALC icon
Alcon
ALC
+$87.1M
3
OTIS icon
Otis Worldwide
OTIS
+$68.8M
4
MRSH
Marsh
MRSH
+$50M
5
MRK icon
Merck
MRK
+$49.8M

Top Sells

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$56M
2
JPM icon
JPMorgan Chase
JPM
+$42.7M
3
AMZN icon
Amazon
AMZN
+$38.8M
4
AGN
Allergan plc
AGN
+$36.5M
5
MSFT icon
Microsoft
MSFT
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 22.31%
2 Healthcare 14.18%
3 Financials 13.68%
4 Consumer Discretionary 11.52%
5 Communication Services 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGEN icon
601
Repligen
RGEN
$9.25B
$2.37M 0.01%
19,177
-19,049
-50% -$2.24M
PEN icon
602
Penumbra
PEN
$12.8B
$2.37M 0.01%
13,249
-10,240
-44% -$1.78M
MITK icon
603
Mitek Systems
MITK
$834M
$2.37M 0.01%
246,370
+29,619
+14% +$267K
PEGA icon
604
Pegasystems
PEGA
$5.38B
$2.37M 0.01%
46,820
-52,698
-53% -$2.28M
CARG icon
605
CarGurus
CARG
$3.47B
$2.36M 0.01%
93,219
-99,627
-52% -$2.32M
RGLD icon
606
Royal Gold
RGLD
$19.5B
$2.36M 0.01%
18,980
-19,997
-51% -$2.42M
HSTM icon
607
HealthStream
HSTM
$840M
$2.36M 0.01%
106,533
-49,856
-32% -$1.15M
WST icon
608
West Pharmaceutical
WST
$24.9B
$2.36M 0.01%
10,376
-14,499
-58% -$2.85M
NEOG icon
609
Neogen
NEOG
$2.5B
$2.36M 0.01%
60,734
-53,654
-47% -$1.81M
QLYS icon
610
Qualys
QLYS
$6.35B
$2.36M 0.01%
22,651
-18,661
-45% -$1.96M
AMBA icon
611
Ambarella
AMBA
$3.81B
$2.35M 0.01%
51,397
-23,992
-32% -$1.24M
BMI icon
612
Badger Meter
BMI
$4.03B
$2.35M 0.01%
37,397
-34,502
-48% -$2.05M
TU icon
613
Telus
TU
$15.3B
$2.35M 0.01%
140,884
+138
+0.1% +$2.3K
HMSY
614
DELISTED
HMS Holdings Corp.
HMSY
$2.35M 0.01%
+72,525
New +$2.1M
CDXS icon
615
Codexis
CDXS
$158M
$2.35M 0.01%
205,937
-130,126
-39% -$1.47M
INSP icon
616
Inspire Medical Systems
INSP
$1.74B
$2.35M 0.01%
26,985
-36,078
-57% -$2.77M
KURA icon
617
Kura Oncology
KURA
$850M
$2.35M 0.01%
144,064
-104,525
-42% -$1.51M
NVCR icon
618
NovoCure
NVCR
$1.91B
$2.35M 0.01%
39,581
-14,476
-27% -$952K
FIVN icon
619
FIVE9
FIVN
$2.54B
$2.35M 0.01%
21,202
-25,653
-55% -$2.5M
RAVN
620
DELISTED
Raven Industries Inc
RAVN
$2.34M 0.01%
108,995
-55,371
-34% -$1.17M
NDSN icon
621
Nordson
NDSN
$17.3B
$2.34M 0.01%
12,353
-14,118
-53% -$2.39M
ATR icon
622
AptarGroup
ATR
$8.61B
$2.34M 0.01%
20,904
-16,648
-44% -$1.77M
FRPT icon
623
Freshpet
FRPT
$3.22B
$2.34M 0.01%
27,988
-30,683
-52% -$2.31M
EPAM icon
624
EPAM Systems
EPAM
$5.03B
$2.34M 0.01%
9,282
-10,422
-53% -$2.29M
ENTA icon
625
Enanta Pharmaceuticals
ENTA
$400M
$2.34M 0.01%
46,570
-28,464
-38% -$1.47M

Similar funds

Aviva's Q2 2020 Portfolio in Review

As of Q2 2020, Aviva held 979 positions worth $16B, up 18% from $13.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Aviva's Q2 2020 filing shows 49 new, 147 increased, 723 reduced and 36 closed positions. Its largest new stake was Otis Worldwide: 1,327,192 shares worth $75.5M. The largest sale was Raytheon Company, an estimated $56M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Aviva's largest Q2 2020 buy was Otis Worldwide: 1,327,192 shares worth $75.5M.
  • Aviva added most to Union Pacific in Q2 2020, an estimated $101M increase.
  • Aviva's biggest Q2 2020 reduction was JPMorgan Chase, cutting an estimated $42.7M.
  • Aviva fully exited Raytheon Company in Q2 2020, selling an estimated $56M.
  • Aviva's ten largest holdings make up 24% of its $16B portfolio in Q2 2020.
  • Aviva opened 49 new positions and closed 36 in Q2 2020.
  • Aviva's portfolio value rose 18% quarter-over-quarter to $16B.

Based on Aviva's 13F filing for Q2 2020, filed 13 Aug 2020.